Literature DB >> 13576192

Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment.

S A FRANKEL, W J GERMAN.   

Abstract

Entities:  

Keywords:  GLIOBLASTOMA MULTIFORME/case reports

Mesh:

Year:  1958        PMID: 13576192     DOI: 10.3171/jns.1958.15.5.0489

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  41 in total

Review 1.  Historical development of surgery for glial tumors.

Authors:  M Salcman
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Long-term survival in a patient with supratentorial glioblastoma: clinical considerations.

Authors:  L Cervoni; P Celli; M Salvati
Journal:  Ital J Neurol Sci       Date:  1998-08

3.  QUALITY OF SURVIVAL IN TREATED PATIENTS WITH SUPRATENTORIAL GLIOMATA.

Authors:  M J BETTY
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

4.  A look ahead at technical and training developments in neurosurgery.

Authors:  J L POOL
Journal:  Bull N Y Acad Med       Date:  1959-11

5.  Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme.

Authors:  H G Höllerhage; M Zumkeller; M Becker; H Dietz
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

6.  Differences between neurological and neurosurgical approaches in the management of malignant brain tumours.

Authors:  S J Wroe; P M Foy; M D Shaw; I R Williams; D W Chadwick; C West; G Towns
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-18

7.  Chemotherapy of Malignant Brain Tumors Using Regional Perfusion: I. Technic and Patient Selection.

Authors:  H A Aronson; S Flanigan; J B Mark
Journal:  Ann Surg       Date:  1963-03       Impact factor: 12.969

8.  Grading of astrocytomas using a Quantimet 720 image-analysing computer.

Authors:  A J Robertson; J M Anderson; R A Brown; W Slidders; J S Beck
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

9.  Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort.

Authors:  Yazmin Odia; Joanna H Shih; Teri N Kreisl; Howard A Fine
Journal:  J Neurooncol       Date:  2014-08-07       Impact factor: 4.130

10.  A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.

Authors:  Yazmín Odia; Teri N Kreisl; Dawit Aregawi; Ellen K Innis; Howard A Fine
Journal:  J Neurooncol       Date:  2015-08-19       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.